Florida legislation · 2026 Regular Session
Florida H293: Continuous Glucose Monitors
Status: Failed, March 13, 2026
Requires AHCA to, within specified timeframe, seek federal approval as needed to provide coverage of continuous glucose monitors & related supplies as durable medical equipment benefit under Medicaid program; provides for reimbursement of such equipment; provides construction; requires agency to implement these changes upon receiving any necessary federal approval.
What the bill says
An act relating to continuous glucose monitors; requiring the Agency for Health Care Administration to, within a specified timeframe, seek federal approval as needed to provide coverage of continuous glucose monitors and related supplies as a durable medical equipment benefit under the Medicaid program; providing for the reimbursement of such equipment; providing construction; requiring the agency to implement these changes upon receiving any necessary federal approval; providing an effective date.
From the introduced text, November 3, 2025:
A bill to be entitled An act relating to continuous glucose monitors; requiring the Agency for Health Care Administration to, within a specified timeframe, seek federal approval as needed to provide coverage of continuous glucose monitors and related supplies as a durable medical equipment benefit under the Medicaid program; providing for the reimbursement of such equipment; providing construction; requiring the agency to implement these changes upon receiving any necessary federal approval; providing an effective date. Be It Enacted by the Legislature of the State of Florida: Section 1. (1) Within 30 days after this act becomes a law, the Agency for Health Care Administration shall seek federal approval through a Medicaid waiver or state plan amendment as needed to provide coverage of continuous glucose monitors and related supplies as a durable medical equipment benefit for Medicaid recipients. A licensed durable medical equipment provider must be reimbursed for continuous glucose monitors and related supplies, provided the claim is submitted through an active Medicare Healthcare Common Procedure Coding System. The agency may not require such provider to use a National Drug Code number as part of such claim submission. words underlined are additions. hb293-00 FLORIDAHOUSEOFREPRESENTATIVES HB 293 2026 (2) This section does not preclude the agency from providing additional coverage of continuous glucose monitors as a Medicaid pharmacy benefit. (3) The agency …
Sponsors
- Franklin, Gallop (D, HD-008) · primary sponsor
- Franklin (D, 8) · primary sponsor
Latest actions
- : Died in Health Care Facilities & Systems Subcommittee
- : 1st Reading (Original Filed Version)
- : Now in Health Care Facilities & Systems Subcommittee
- : Referred to Health & Human Services Committee
- : Referred to Health Care Budget Subcommittee
- : Referred to Health Care Facilities & Systems Subcommittee
- : Filed
Common questions
- What is H293?
- H293 is a bill in the Florida Legislature (2026 Regular Session): Continuous Glucose Monitors.
- What does H293 do?
- In its own words: An act relating to continuous glucose monitors; requiring the Agency for Health Care Administration to, within a specified timeframe, seek federal approval as needed to provide coverage of continuous glucose monitors and related supplies as a durable medical equipment benefit under the Medicaid program; providing for the reimbursement of such equipment; providing construction; requiring the agency to implement these changes upon receiving any necessary federal approval; providing an effective date.
- What is the status of H293?
- Failed as of March 13, 2026. Latest action: Died in Health Care Facilities & Systems Subcommittee (March 13, 2026).
- Who sponsored H293?
- Franklin, Gallop (D, HD-008), with 1 co-sponsor.
- Where is the official record for H293?
- On the Florida Legislature website: https://www.flsenate.gov/Session/Bill/2026/293
Source: official Florida record. Tracked by Delilah, AI for legislation across all 50 states and Congress.